The loss of WT p53 functions is the primary outcome of TP53 mutations, while the gain-of-function mutant p53 proteins enhance tumor progression, metastatic potential, and drug resistance, greatly contributing to malignant properties of cancer cells[29]. This evidence concerns the gene TP53 and cancer.